22 September 2020
EU Commission supports international clinical research network to treat COVID-19
An ambitious new EU-funded research initiative, EU-RESPONSE, will establish a clinical research network to treat COVID-19 and other emerging infectious diseases. The Commission announced on 18 September 2020 that it will support the project with €15.7 million.
The EU-RESPONSE consortium, led by the Institut National de la Santé et de la Recherche Médicale (INSERM), brings together 21 partners with world-class research capabilities from 13 EU countries, Norway, Switzerland and Turkey, to build a European network for adaptive platform trials (APTs) for COVID-19 and emerging infectious diseases. APTs have an innovative randomised controlled trial design, which enables various therapies for a disease to be studied simultaneously.
The SCTO is the project partner for Switzerland through its observer status in the European Clinical Research Infrastructure Network (ECRIN) that will play a role in the realisation of the project’s key objectives.
Read more about the project EU-RESPONSE in the fact sheet below and on the European Commission’s and ECRIN’s websites: